Assenmacher Joseph A MD Oregon, OH - 43616

Assenmacher Joseph A MD is categorized under Internal Medicine Doctors in Oregon, OH and active since 2010.

Assenmacher Joseph A MD was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Joseph Assenmacher at the company’s single location by writing to 2751 Bay Park Drive # 201, Oregon, Ohio OH 43616 or by phoning (419) 690-8811. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Assenmacher Joseph A MD
Contact Person: Joseph Assenmacher
Address: 2751 Bay Park Drive # 201, Oregon, Ohio 43616
Phone Number: (419) 690-8811
Website Address: promedica.org/doctors
Annual Revenue (USD): $100.000 to $499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Assenmacher Joseph A MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Joseph Assenmacher for inquiries that concern Assenmacher Joseph A MD by calling the company number (419) 690-8811, as your correspondence is most welcome. Additionally, the physical location of the single location of Assenmacher Joseph A MD can be found at the coordinates 41.61966,-83.48022 as well as the street address 2751 Bay Park Drive # 201 in Oregon, Ohio 43616.

For its online presence, you may visit Assenmacher Joseph A MD’s website at promedica.org/doctors and engage with its social media outlets through on Twitter and on Facebook.